UK medicines innovation must be supported post-Brexit, says RPS chief scientist
It is “absolutely critical” that any drop in the number of clinical trials evaluations within the UK is resisted as Brexit nears, Gino Martini, chief scientist for the Royal Pharmaceutical Society, told a parliamentary meeting.…